Your Health Plan:
Your Health Plan:
Not SelectedVIDAZA (azacitidine) is a brand-name prescription drug for treatment of Refractory anemia, without ringed sideroblasts, without excess blasts, Neutropenia, Thrombocytopenia and Refractory anemia with excess blasts in transformation (clinical). VIDAZA is a nucleoside metabolic inhibitor. It is available in the form of intravenous injection / subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $690-810.
Patient Assistance Prorgams are found:
Other alternatives to VIDAZA may include:
